ConductScience.org, home

Trial · NCT03355664

Adverse events56

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
othervomitingGastrointestinal disordersArtemether-lumefantrine for 3 Days Plus Primaquine at Hour 243154
othervomitingGastrointestinal disordersArtemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 2412156
othernauseaGastrointestinal disordersArtemether-lumefantrine for 3 Days Plus Primaquine at Hour 243154
othernauseaGastrointestinal disordersArtemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 2411156
otherdizzinessGeneral disordersArtemether-lumefantrine for 3 Days Plus Primaquine at Hour 249154
otherdizzinessGeneral disordersArtemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 2416156
otherabdominal painGastrointestinal disordersArtemether-lumefantrine for 3 Days Plus Primaquine at Hour 2419154
otherabdominal painGastrointestinal disordersArtemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 2422156
otherdiarrhoeaGastrointestinal disordersArtemether-lumefantrine for 3 Days Plus Primaquine at Hour 2413154
otherdiarrhoeaGastrointestinal disordersArtemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 2417156
otherheadacheGeneral disordersArtemether-lumefantrine for 3 Days Plus Primaquine at Hour 2419154
otherheadacheGeneral disordersArtemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 2420156
otherfatigueGeneral disordersArtemether-lumefantrine for 3 Days Plus Primaquine at Hour 2411154
otherfatigueGeneral disordersArtemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 2415156
otherloss of appetiteGeneral disordersArtemether-lumefantrine for 3 Days Plus Primaquine at Hour 249154
otherloss of appetiteGeneral disordersArtemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 249156
otheritchingSkin and subcutaneous tissue disordersArtemether-lumefantrine for 3 Days Plus Primaquine at Hour 242154
otheritchingSkin and subcutaneous tissue disordersArtemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 245156
otherblurred visionEye disordersArtemether-lumefantrine for 3 Days Plus Primaquine at Hour 247154
otherblurred visionEye disordersArtemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 244156

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03355664/events